Skip to the beginning of the images gallery

(1R, 2S, 5S)-2-Amino Edoxaban

Availability:In stock

Edoxaban Impurity 41 (1R,2S,5S)

unit

Quantity:

Note:

All Products are stable to be shipped at room temperature, unless otherwise specified.

Synonyms :N-((1R,2S,5S)-2-Amino-5-(dimethylcarbamoyl)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide; Edoxaban Impurity 41

Description

Synonyms: N-((1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide

More Information

More Information
SKU	RCLSTE80046
CAS number	480450-71-3
Molecular Formula	C17H27N5O2S
Catalog Number	RCLSTE80046
Chemical Name	(1R, 2S, 5S)-2-Amino Edoxaban
Synonyms	N-((1R,2S,5S)-2-Amino-5-(dimethylcarbamoyl)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide; Edoxaban Impurity 41
Molecular Weight	365.50
Solubility	Methanol, Water, Acetonitrile
Stability	Hygroscopic material
Appearance	Pale Yellow Solid
Storage Condition	Store a Refrigerator (2-8°C) for a prolonged period
Shipping Info	All Products Are Stable To Be Shipped At Room Temperature, Unless Otherwise Specified
Application Note	Compounds Can Strictly Be Provided For Research And Development Purposes. Compounds Are Not Intended For Animal/Human Testing And/Or Usage

Products

Purity : ≥95%

Appearance: Pale Yellow Solid

Synonyms : Des((2-((5-chloro-2-pyridyl)amino)-2-oxo-acetyl))edoxaban; Edoxaban-M2,Edoxaban Impurity 41 (1R,2S,5S)

IUPAC Name : N-[(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]-5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carboxamide

InChI Key: QJVMDGXTANLPMW-GMXVVIOVSA-N

InChI : InChI=1S/C17H27N5O2S/c1-21(2)17(24)10-4-5-11(18)13(8-10)19-15(23)16-20-12-6-7-22(3)9-14(12)25-16/h10-11,13H,4-9,18H2,1-3H3,(H,19,23)/t10-,11-,13+/m0/s1

Canonical SMILES : CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3N)C(=O)N(C)C

Applications: This is an impurity of Edoxaban . Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor

References : Ruff, C., et al.: Am. Heart J., 160, 635 (2010); Ogata, K., et al.: J. Clin. Pharm., 50, 73 (2010);